EPIK-P1


Study Name Study Title Study Type Sponsor Sponsor Type
EPIK-P1 Retrospective Chart Review Study of Patients with PIK3CA- Related Overgrowth Spectrum (PROS) who have received alpelisib as part of a compassionate use program. Non-Interventional Study Novartis Industry Sponsored